Intra-cellular therapies to present at the evercore isi 3rd annual healthconx conference

New york, nov. 30, 2020 (globe newswire) -- intra-cellular therapies, inc. (nasdaq:itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that sharon mates, ph.d., chief executive officer and chairman, is scheduled to participate in a fireside chat at the evercore isi 3rd annual healthconx conference on wednesday, december 2, 2020 at 9:15am et.
ITCI Ratings Summary
ITCI Quant Ranking